BRIEF published on 08/08/2025 at 23:35, 1 year ago La FDA approuve le système Genio® de Nyxoah pour le traitement de l'apnée obstructive du sommeil Approbation De La FDA Nyxoah Apnée Obstructive Du Sommeil Commercialisation Aux États-Unis Système Genio
PRESS RELEASE published on 08/08/2025 at 23:30, 1 year ago Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea Nyxoah receives FDA approval for Genio System, advancing OSA treatment with bilateral stimulation and leadless technology. U.S. commercialization launched FDA Approval Nyxoah Obstructive Sleep Apnea Neuromodulation Genio System
BRIEF published on 07/28/2025 at 22:10, 1 year 1 month ago Nyxoah’s DREAM Study Data Featured in Clinical Journal Obstructive Sleep Apnea DREAM Study Clinical Outcomes Genio® System Patient Satisfaction
BRIEF published on 07/28/2025 at 22:10, 1 year 1 month ago Les données de l'étude DREAM de Nyxoah présentées dans une revue clinique Résultats Cliniques Apnée Obstructive Du Sommeil Étude DREAM Système Genio® Satisfaction Des Patients
PRESS RELEASE published on 07/28/2025 at 22:05, 1 year 1 month ago Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Nyxoah's DREAM pivotal study data on Genio system for OSA treatment published in Journal of Clinical Sleep Medicine. Study shows high patient satisfaction & improved quality of life Sleep Medicine Nyxoah Genio System DREAM Pivotal Study OSA Treatment
BRIEF published on 05/14/2025 at 07:05, 1 year 3 months ago Nyxoah Reports First Quarter 2025 Financial and Operating Results Financial Results FDA Approval Nyxoah Q1 2025 Genio System
BRIEF published on 05/14/2025 at 07:05, 1 year 3 months ago Nyxoah publie ses résultats financiers et opérationnels du premier trimestre 2025 Résultats Financiers Approbation De La FDA Nyxoah Système Genio T1 2025
PRESS RELEASE published on 05/14/2025 at 07:00, 1 year 3 months ago Nyxoah Reports First Quarter Financial and Operating Results Nyxoah reports financial and operating results for the first quarter of 2025, including progress towards FDA PMA approval for the Genio® system. Revenue €1.1 million. Cash position €63.0 million Financial Results FDA Approval Operating Highlights Nyxoah Genio® System
BRIEF published on 04/08/2025 at 07:05, 1 year 4 months ago Nyxoah informe sur le processus d'approbation du système Genio par la FDA Technologie Médicale Approbation De La FDA Nyxoah Apnée Obstructive Du Sommeil Système Genio
BRIEF published on 04/08/2025 at 07:05, 1 year 4 months ago Nyxoah Updates on FDA Approval Process for Genio System FDA Approval Medical Technology Nyxoah Obstructive Sleep Apnea Genio System
Published on 09/08/2026 at 01:45, 4 hours 31 minutes ago Tunkillia Environmental Scoping Report Approved
Published on 09/05/2026 at 04:05, 3 days 2 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 3 days 6 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 days 7 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 3 days 7 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/07/2026 at 19:19, 10 hours 57 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Sales and Adjusted EBIT in Q2 2026/27 above prior-year level – FY outlook maintained
Published on 09/07/2026 at 19:00, 11 hours 16 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 31 août 2026 au 4 septembre 2026
Published on 09/07/2026 at 18:42, 11 hours 34 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/07/2026 at 18:00, 12 hours 16 minutes ago E-PANGO: e-Pango organise un webinaire avec ses actionnaires
Published on 09/07/2026 at 17:45, 12 hours 31 minutes ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 09/07/2026 at 19:00, 11 hours 16 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026
Published on 09/07/2026 at 19:00, 11 hours 16 minutes ago Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 12 hours 11 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026
Published on 09/07/2026 at 18:05, 12 hours 11 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026
